These findings strengthen the role of c-Abl in AD and suggest that synaptic changes associated with the deficiency of c-Abl contribute to the mechanisms involved in decreasing early AD pathology and the progression of cognitive decline. Here, ABL1 is linked to Alzheimer disease.